FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2020/12/029746 [Registered on: 11/12/2020] Trial Registered Prospectively
Last Modified On: 16/08/2023
Post Graduate Thesis  No 
Type of Trial  Observational 
Type of Study   Cross Sectional Study 
Study Design  Single Arm Study 
Public Title of Study   Post Market Clinical Follow Up Investigation of Intraskan DC 
Scientific Title of Study   A prospective, post market, non-interventional observational, open label, single arm, single center study to validate the clinical safety and performance of Intraskan DC 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
23-Nov-2020  Other 
PLN-000692-0-20 Version 01  Protocol Number 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Jaishankar H P 
Designation  Reader 
Affiliation  JSS Dental College and Hospital 
Address  Department of Oral Medicine and Radiology, JSS Dental College & Hospital, Sri Shivarathreeshwara Nagara, Mysore

Mysore
KARNATAKA
570015
India 
Phone  9448106487  
Fax    
Email  drjaishankarhp_dch@jssuni.edu.in  
 
Details of Contact Person
Scientific Query
 
Name  Dr Jaishankar H P 
Designation  Reader 
Affiliation  JSS Dental College and Hospital 
Address  Department of Oral Medicine and Radiology, JSS Dental College & Hospital, Sri Shivarathreeshwara Nagara, Mysore


KARNATAKA
570015
India 
Phone  9448106487  
Fax    
Email  drjaishankarhp_dch@jssuni.edu.in  
 
Details of Contact Person
Public Query
 
Name  Vasundhara R 
Designation  Head- Regulatory Affairs 
Affiliation  Skanray Technologies Pvt Ltd 
Address  Department of Regulatory Affairs Skanray Technologies Pvt Ltd Plot 15 16 17 Hebbal Industrial Area Mysore

Mysore
KARNATAKA
570016
India 
Phone  9844761818  
Fax    
Email  vasundhara.r@skanray.com  
 
Source of Monetary or Material Support  
Skanray Technologies Pvt Ltd Plot 15 16 17 Hebbal Industrial Area Mysore 570016 
 
Primary Sponsor  
Name  Skanray Technologies Pvt Ltd 
Address  Plot 15 16 17 Hebbal Industrial Area Mysore 570016 
Type of Sponsor  Other [Medical Device Manufacturer] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Jaishankar H P  JSS Dental College and Hospital  Department of Oral Medicine and Radiology, JSS Dental College & Hospital, Sri Shivarathreeshwara Nagara, Mysore
Mysore
KARNATAKA 
9448106487

drjaishankarhp_dch@jssuni.edu.in 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee JSS Medical College and Hospital  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: K038||Other specified diseases of hard tissues of teeth,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Nil  Nil 
Comparator Agent  Nil  Nil 
 
Inclusion Criteria  
Age From  1.00 Year(s)
Age To  99.00 Year(s)
Gender  Both 
Details  Male and female subjects of all age groups.
Subjects or legally authorized representatives or guardians on behalf of the subject who are able and willing to provide written informed consent to participate in this clinical investigation.
 
 
ExclusionCriteria 
Details  Pregnant or suspected to be pregnant based on the opinion of a physician.
Infant of age less than 1 year.  
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Collection of feedback which includes investigator’s assessment of the overall safety and performance of the devices Intraskan DC found to be appropriate to meet the predefined objectives.  Within 14 days after capturing the radiographic
images. 
 
Secondary Outcome  
Outcome  TimePoints 
Collection of feedback from the investigator on the radiographic images collected during the study and usability. This shall meet the predefined objectives to prove the claimed performance of Intraskan DC  Within 14 days after capturing the radiographic images. 
 
Target Sample Size   Total Sample Size="300"
Sample Size from India="300" 
Final Enrollment numbers achieved (Total)= "0"
Final Enrollment numbers achieved (India)="0" 
Phase of Trial   N/A 
Date of First Enrollment (India)   14/12/2020 
Date of Study Completion (India) Date Missing 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Date Missing 
Estimated Duration of Trial   Years="0"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Applicable 
Recruitment Status of Trial (India)  Completed 
Publication Details   Nil 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  
This is a post market clinical follow up investigation to validate the safety and performance of Intraskan DC. 
 
Close